Peer Review reports
From: Real-life experiences with galcanezumab and predictors for treatment response in Turkey
| Original Submission | ||
|---|---|---|
| 24 Sep 2023 | Submitted | Original manuscript |
| 4 Oct 2023 | Reviewed | Reviewer Report |
| 4 Oct 2023 | Reviewed | Reviewer Report |
| 29 Oct 2023 | Author responded | Author comments - Pınar Yalınay Dikmen |
| Resubmission - Version 2 | ||
| 29 Oct 2023 | Submitted | Manuscript version 2 |
| 30 Oct 2023 | Author responded | Author comments - Pınar Yalınay Dikmen |
| Resubmission - Version 3 | ||
| 30 Oct 2023 | Submitted | Manuscript version 3 |
| 2 Nov 2023 | Reviewed | Reviewer Report |
| 6 Nov 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Publishing | ||
| 13 Nov 2023 | Editorially accepted | |
| 23 Nov 2023 | Article published | 10.1186/s12883-023-03467-1 |
You can find further information about peer review here.